We are a biotechnology company dedicated to curing Alzheimer's disease. We are planning FDA-sponsored human trials, using telomerase therapy to reset cell aging within the central nervous system. We believe that Alzheimer's disease can stopped, prevented, and cured.
Looking for a particular Telocyte employee's phone or email?
The Telocyte annual revenue was $3 million in 2026.
Mark Hodges is the Board Member of Telocyte.
3 people are employed at Telocyte.
Telocyte is based in Grand Rapids, Michigan.
The NAICS codes for Telocyte are [54172, 5417, 541, 541720, 54].
The SIC codes for Telocyte are [87, 873].